Endometrioid Carcinoma Arising from an Endometriosis-Associated Abdominal Wall Scar.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
01 Jun 2020
01 Jun 2020
Historique:
entrez:
2
6
2020
pubmed:
2
6
2020
medline:
29
1
2021
Statut:
epublish
Résumé
BACKGROUND Carcinoma arising from an endometriosis-associated abdominal wall scar is a rare entity, with only a few case reports published in the literature. The management is very controversial due to on its own rarity, and there are no specific guidelines. Treatment with a multidisciplinary team is important to achieve the best outcome. CASE REPORT We report the case of a 45-year-old woman diagnosed with a growing painless lesion in the right lower quadrant. We decided to perform Tru-Cut biopsy of the abdominal wall lesion, but unfortunately the pathological report was inconclusive at that time. Due to the presence of a highly suspicious lesion, the gynecologic oncologist together with the plastic surgeon and connective tissue surgeon decided to perform a wide resection of the abdominal wall along with hysterectomy and salpingo-oophorectomy. The final pathology report demonstrated endometriosis associated with an endometrioid adenocarcinoma grade II in the abdominal wall tumor. She was restaged with new imaging exams before the definition of the best adjuvant treatment, which showed suspicious bilateral inguinal and right axillary (1.9 cm) lymph nodes, with no other sites of metastatic disease. She was treated with megestrol acetate 160 mg/daily for 8 months, with a partial response. CONCLUSIONS Carcinoma arising from an endometriosis-associated abdominal wall scar is a rare entity, and there are no no specific treatment guidelines. Such patients must be assessed by a multidisciplinary team for decision making. Options for adjuvant and palliative treatment for endometrial cancer are generally used for the treatment of this entity. The main purpose of this article is to report this rare presentation and perform a review of the literature about diagnosis, clinical presentation, treatment, and prognosis.
Identifiants
pubmed: 32479429
pii: 922973
doi: 10.12659/AJCR.922973
pmc: PMC7295312
doi:
Substances chimiques
Megestrol Acetate
TJ2M0FR8ES
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e922973Références
Medicine (Baltimore). 2017 Dec;96(49):e9136
pubmed: 29245355
J Reprod Immunol. 2002 May-Jun;55(1-2):49-64
pubmed: 12062821
Fertil Steril. 2008 Mar;89(3):538-45
pubmed: 17498711
Am Surg. 1996 Dec;62(12):1042-4
pubmed: 8955245
Int J Gynecol Cancer. 2015 Nov;25(9):1633-8
pubmed: 26448542
BMJ. 2014 Mar 19;348:g1752
pubmed: 24647161
Obstet Gynecol. 1953 Sep;2(3):283-9
pubmed: 13087921
Fertil Steril. 2006 Aug;86(2):298-303
pubmed: 16828481
Cancer. 2002 Jun 1;94(11):2935-40
pubmed: 12115382
Int J Cancer. 2002 Dec 1;102(4):398-406
pubmed: 12402310
Mod Pathol. 2006 Jan;19(1):83-9
pubmed: 16258507
Geburtshilfe Frauenheilkd. 2016 Feb;76(2):176-181
pubmed: 26941451
Obstet Gynecol. 1986 Mar;67(3):335-8
pubmed: 3945444
Int J Gynecol Pathol. 2006 Jul;25(3):223-9
pubmed: 16810057
Nat Rev Endocrinol. 2014 May;10(5):261-75
pubmed: 24366116
Int J Gynaecol Obstet. 2005 Sep;90(3):218-22
pubmed: 16040035
Obstet Gynecol. 2002 Oct;100(4):788-95
pubmed: 12383550
Best Pract Res Clin Obstet Gynaecol. 2004 Apr;18(2):349-71
pubmed: 15157647
World J Surg Oncol. 2016 Dec 3;14(1):300
pubmed: 27912770
Hum Pathol. 2007 Nov;38(11):1676-87
pubmed: 17707463
Cancer. 2003 Oct 15;98(8):1658-63
pubmed: 14534882
AJR Am J Roentgenol. 2006 Mar;186(3):616-20
pubmed: 16498086
Int J Environ Res Public Health. 2019 Feb 14;16(4):
pubmed: 30769847
Nat Med. 2005 Jan;11(1):63-70
pubmed: 15619626